These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 27230923

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Kinetic analysis and quantification of the dopamine transporter in the nonhuman primate brain with 11C-PE2I and 18F-FE-PE2I.
    Varrone A, Tóth M, Steiger C, Takano A, Guilloteau D, Ichise M, Gulyás B, Halldin C.
    J Nucl Med; 2011 Jan; 52(1):132-9. PubMed ID: 21189414
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.
    Kawaguchi H, Shimada H, Kodaka F, Suzuki M, Shinotoh H, Hirano S, Kershaw J, Inoue Y, Nakamura M, Sasai T, Kobayashi M, Suhara T, Ito H.
    PLoS One; 2016 Jan; 11(3):e0151191. PubMed ID: 26954690
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility.
    Hirvonen J, Johansson J, Teräs M, Oikonen V, Lumme V, Virsu P, Roivainen A, Någren K, Halldin C, Farde L, Hietala J.
    J Cereb Blood Flow Metab; 2008 May; 28(5):1059-69. PubMed ID: 18183028
    [Abstract] [Full Text] [Related]

  • 32. Clinical correlates of dopamine transporter availability in cross-sectional and longitudinal studies with [18F]FE-PE2I PET: independent validation with new insights.
    Honhar P, Ebrahimian Sadabad F, Tinaz S, Gallezot JD, Dias M, Naganawa M, Yang Y, Henry S, Hillmer AT, Gao H, Najafzadeh S, Comley R, Nabulsi N, Huang Y, Finnema SJ, Carson RE, Matuskey D.
    Brain Commun; 2024 May; 6(5):fcae345. PubMed ID: 39429243
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. VNTR polymorphism in the SLC6A3 gene does not influence dopamine transporter availability measured by [18F]FE-PE2I PET or [123I]FP-Cit SPECT.
    Jakobson Mo S, Axelsson J, Stiernman LJ, Larsson A, Af Bjerkén S, Bäckström D, Kellgren TG, Varrone A, Riklund K.
    Nucl Med Commun; 2022 Mar 01; 43(3):247-255. PubMed ID: 34908018
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding.
    Varnäs K, Cselényi Z, Jucaite A, Halldin C, Svenningsson P, Farde L, Varrone A.
    Eur J Nucl Med Mol Imaging; 2019 Feb 01; 46(2):367-375. PubMed ID: 30270409
    [Abstract] [Full Text] [Related]

  • 38. Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers.
    Ribeiro MJ, Ricard M, Lièvre MA, Bourgeois S, Emond P, Gervais P, Dollé F, Syrota A.
    Nucl Med Biol; 2007 May 01; 34(4):465-70. PubMed ID: 17499737
    [Abstract] [Full Text] [Related]

  • 39. [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.
    Halldin C, Erixon-Lindroth N, Pauli S, Chou YH, Okubo Y, Karlsson P, Lundkvist C, Olsson H, Guilloteau D, Emond P, Farde L.
    Eur J Nucl Med Mol Imaging; 2003 Sep 01; 30(9):1220-30. PubMed ID: 12811422
    [Abstract] [Full Text] [Related]

  • 40. Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET in healthy individuals.
    Jonasson M, Frick A, Fazio P, Hjorth O, Danfors T, Axelsson J, Appel L, Furmark T, Varrone A, Lubberink M.
    J Cereb Blood Flow Metab; 2023 Jul 01; 43(7):1206-1215. PubMed ID: 36912083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.